CATO Associate Protocol Development & Study Design Flashcards
7 cards from real CCA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 CATO Associate Protocol Development & Study Design flashcards as text
Which section of a clinical trial protocol defines the scientific rationale and purpose of the study?
Answer: Background and Introduction
The Background and Introduction section provides the scientific rationale, prior research, and purpose that justify conducting the study.
What is the primary purpose of inclusion and exclusion criteria in a clinical trial protocol?
Answer: To define the target study population and ensure participant safety
Inclusion and exclusion criteria define who may participate, ensuring the study population matches the scientific objectives and that vulnerable or at-risk individuals are appropriately protected.
A Phase II clinical trial is primarily designed to:
Answer: Assess preliminary efficacy and dosing in patients with the target disease
Phase II trials focus on evaluating preliminary efficacy, determining optimal dosing, and further characterizing safety in patients who have the disease being studied.
What is the purpose of a protocol synopsis?
Answer: To provide a concise summary of the key elements of the study protocol
A protocol synopsis is a condensed summary of the most critical protocol elements, often used for IRB/IEC submissions, feasibility assessments, or internal reviews.
In a randomized controlled trial (RCT), what does 'blinding' primarily aim to prevent?
Answer: Bias in outcome assessment and participant behavior
Blinding prevents knowledge of treatment assignment from influencing participant behavior or outcome assessors' evaluations, thereby reducing bias.
Which term describes the document that specifies changes made to an approved clinical trial protocol?
Answer: Protocol Amendment
A protocol amendment is a formal written document describing changes to an approved protocol and must typically be approved by the IRB/IEC and regulatory authorities before implementation.
Which study design is considered the gold standard for evaluating the efficacy of a new treatment?
Answer: Randomized double-blind placebo-controlled trial
The randomized double-blind placebo-controlled trial minimizes bias through randomization, blinding, and a control comparator, making it the gold standard for establishing treatment efficacy.